Effectiveness and acceptability of a 24-h interval versus a 48-h interval between mifepristone intake and misoprostol administration for in-hospital abortion at 9–20 gestational weeks: an international, open-label, randomised, controlled, non-inferiority trial

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(24)00416-9/fulltext?dgcid=hubspot_update_feature_updatealerts_langlo&utm_campaign=update-langlo&utm_medium=email&_hsenc=p2ANqtz-9dCmtb39u4VP4g_Y9h8sWp46fXn3PLaBH7sE7h6Wfaensx7eWX9wpJ3UA7qGZ_wx7PSrLd_gP5lkqib23AVdw6nfZ5LQ&_hsmi=341259473&utm_content=341249912&utm_source=hs_email